Skip to main content
Arbutus Biopharma Corporation (ABUS)
NASDAQ: ABUS · Real-Time Price · USD
4.530
-0.170 (-3.62%)
At close: Mar 6, 2026, 4:00 PM EST
4.490
-0.040 (-0.88%)
After-hours: Mar 6, 2026, 7:57 PM EST

Arbutus Biopharma Revenue

Arbutus Biopharma had revenue of $529.00K in the quarter ending September 30, 2025, a decrease of -60.49%. This brings the company's revenue in the last twelve months to $14.61M, up 116.64% year-over-year. In the year 2024, Arbutus Biopharma had annual revenue of $6.17M, down -65.98%.

Revenue (ttm)
$14.61M
Revenue Growth
+116.64%
P/S Ratio
59.65
Revenue / Employee
$331,955
Employees
44
Market Cap
871.23M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20246.17M-11.97M-65.98%
Dec 31, 202318.14M-20.88M-53.51%
Dec 31, 202239.02M28.03M255.11%
Dec 31, 202110.99M4.07M58.92%
Dec 31, 20206.91M903.00K15.02%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Fortrea Holdings 2.72B
Arvinas 262.60M
Maravai LifeSciences Holdings 185.74M
Phathom Pharmaceuticals 175.11M
ARS Pharmaceuticals 142.77M
uniQure 16.10M
Evommune 13.00M
Janux Therapeutics 10.00M
Revenue Rankings

ABUS News

More News